Seen in the ED Quiz: 6 Weeks Pregnant with Vaginal Bleeding
The patient is 42-years-old, G2P1 and presents with 1 week of vaginal spotting, 4 days of pelvic pain. Review the ultrasound and lab findings. What's your diagnosis?
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 28, 2020
US confirmed cases of COVID-19 have surpassed 7 million; global cases have reached 33 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 25, 2020
Global confirmed cases of COVID-19 have surpassed 32 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
Genetic Mutations May Underlie Severe COVID-19 Illness
More than 10% of those who develop severe COVID-19 have misguided antibodies that derail the immune response, according to new research.
Patients with T2D at Greater Risk for Vascular than Other Dementias
The association of vascular dementia with T2D is stronger than that of nonvascular or Alzheimer dementia, according to a study presented at EASD.
A New Definition for "Pain"
To redefine the word "pain," the IASP invited ethicists and philosophers to assist in the process. A one-time IASP taxonomy task force member highlights the process.
Pandemic-related “Sexual Distancing,” Declines in Testing Cause Drop in Reported STDs
Sexually distancing and declines in STD testing due to COVID-19 may have caused the recent decline in reported cases of syphilis, gonorrhea, and chlamydia in the US.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 24, 2020
US confirmed cases of COVID-19 number nearly 7 million; global recoveries have surpassed 22 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 23, 2020
How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.
How Do Health Risks Improve After Weight Loss?
The health benefits of sustained weight loss for persons with obesity could be a valuable topic when a discussion is opened.
CDC: Adult Obesity Rising, Racial and Ethnic Disparities Still Exist
New CDC data show 12 states had an adult obesity prevalence of ≥35% in 2019 compared to 9 states in 2018 and 6 states in 2017.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 22, 2020
Global confirmed cases of COVID-19 have surpassed 31 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 21, 2020
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
US Teen Substance Use: A True/False Quiz
Find out how much you know about substance use among US high school students with our 9-question true/false quiz based on the 2019 CDC Youth Risk Behavior Survey results.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 18, 2020
Global confirmed cases of COVID-19 have surpassed 30 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Weight Stigma Predicts Emotional Distress, Binge Eating among Young Adults during COVID-19
Youth who experienced weight stigma prior to COVID-19 were 3-times more likely to engage in binge eating during the pandemic vs those who had not, a new study found.
FDA Puts Empagliflozin on Fast Track for Reduced Post-MI All-cause Mortality
Empagliflozin is now in FDA fast-track development for prevention of hospitalization for HF and reduced all-cause mortality in patients, with/without diabetes, post-AMI.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of September 17, 2020
Asthma: Long-acting Muscarinic Antagonists Overused, Up Exacerbation Risk
Long-acting muscarinic antagonists, recommended as add-on therapy for asthma, are too often used as monotherapy and are linked with severe exacerbations, a new study finds.
FDA Approves First Once-daily Single Inhaler Triple Therapy for Both Asthma, COPD Treatment
Along with COPD, fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) is now approved for the treatment of asthma in patients aged ≥18 years.